Sex Differences in Cardiovascular Research: A Scientometric Analysis
- PMID: 34632817
- PMCID: PMC9075283
- DOI: 10.1161/JAHA.121.021522
Sex Differences in Cardiovascular Research: A Scientometric Analysis
Abstract
Background We sought to investigate sex-specific differences in authorship of cardiovascular research over the past decade. Methods and Results All 387 463 cardiovascular publications between 2010 and 2019 were retrieved from Web of Science. Articles increased from 19 960 to 29 604 articles per year (P>0.001). The number of articles written by female first authors increased by 76.3% (6434-11 343 articles) and by 35.0% for male first authors (13 526-18 261) (P<0.001). The first author was more likely to be a female author in articles with female last authors. The median impact factor (IF) for articles by female first authors was lower (2.46 [interquartile range, 7 1.11-4.03] versus 2.51 [interquartile range, 1.17-4.10]; P<0.001). Female authorship articles reached the highest IF in North America (average IF, 3.7), with the lowest in Africa (average IF, 1.8). Conclusions Publications in cardiovascular research have increased over the past decade, particularly by female authors. Female researchers are cited less often compared with their male peers. The IF remains lower for articles by female researchers.
Keywords: cardiovascular; citation analysis; gender; research; sex.
Conflict of interest statement
Dr Millenaar has received honoraria from Bayer, Boston Scientific, and Daiichi Sankyo. Dr Mehran has received personal fees from Abbott Laboratories, Abiomed, Applied Therapeutics, AstraZeneca, Bayer, Beth Israel Deaconess, Bristol Myers Squibb, CERC, Chiesi, Concept Medical, CSL Behring, DSI, Medtronic, Novartis Pharmaceuticals, OrbusNeich, and Zoll. Dr Al‐Lamee declares speakers’ fees from Philips Volcano and Menarini Pharmaceuticals, outside this work. Dr Ukena received scientific support and speaker honorarium from Medtronic Inc and Recor Medical. Dr Böhm receives honoraria for lectures and scientific advice from Abbott, Astra‐Zeneca, Boehringer‐Ingelheim, Medtronic, Novartis, Servier, and Vifor. Dr Mahfoud has received scientific support and speaker honoraria from Bayer, Boehringer Ingelheim, Medtronic, and ReCor Medical. The remaining authors have no disclosures to report.
Figures
Comment in
-
Important Questions Deserve Rigorous Analysis: A Cautionary Note About Selection Bias.J Am Heart Assoc. 2022 Mar 15;11(6):e023234. doi: 10.1161/JAHA.121.023234. Epub 2021 Oct 11. J Am Heart Assoc. 2022. PMID: 34632821 Free PMC article. No abstract available.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous
